Video Experimental Relacionado
Updated: Jan 7, 2026
14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
10.0K
Etiología de la leucemia mieloide aguda con cariotipo complejo y mutación de TP53
Anna Fedenko1, Honorata Czapinska1, Alwin Krämer2,3
1International Institute of Molecular and Cell Biology, Warsaw, Poland.
Leukemia
|December 19, 2025
Resumen
Las mutaciones de TP53 inician el desarrollo de la leucemia mieloide crónica (LMC). La pérdida de ambos alelos de TP53 y las anomalías cromosómicas posteriores impulsan la progresión de la enfermedad en la LMC sin TP53.
Área de la Ciencia:
- Oncología
- Genética
- Hematología
Sus antecedentes:
- TP53 es un gen supresor de tumores crítico.
- Las mutaciones de TP53 están implicadas en diversos cánceres, incluida la leucemia.
- Comprender el papel de TP53 en la leucemia mieloide crónica (LMC) es crucial para las terapias dirigidas.
Objetivo del estudio:
- Elucidar el papel de las mutaciones del gen TP53 en la patogénesis de la leucemia mieloide crónica (LMC).
- Esbozar los eventos genéticos secuenciales que conducen al desarrollo de la LMC en el contexto de las alteraciones de TP53.
- Proporcionar una visión esquemática del desarrollo de la LMC impulsada por TP53.
Principales métodos:
- Revisión de la literatura existente sobre mutaciones de TP53 en la LMC.
- Análisis de las aberraciones genéticas asociadas con la pérdida de TP53 en la leucemia.
- Desarrollo de un modelo conceptual que ilustra la vía de progresión de la enfermedad.
Principales resultados:
- El evento inicial en la LMC impulsada por TP53 suele ser una mutación dominante-negativa de TP53.
- A esto le sigue rápidamente la pérdida completa del gen TP53 funcional (pérdida del segundo alelo).
- Posteriormente se acumulan aberraciones cromosómicas que contribuyen a la leucemogénesis.
Conclusiones:
- La inactivación de TP53 es un motor clave en un subconjunto de casos de LMC.
- La pérdida de la función de TP53 inicia una cascada de inestabilidad genética.
- La focalización de las vías de TP53 puede ofrecer estrategias terapéuticas para pacientes con LMC y estas mutaciones.
Videos de Conceptos Relacionados
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
02:21Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
01:33Cancer-Critical Genes I: Proto-oncogenes
11.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
00:50Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
02:38The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K